Get the Stockscreener App
2.09
0.00%
0.00
After Hours:
1.98
-0.11
-5.26%
Medicus Pharma Ltd stock is traded at $2.09, with a volume of 40,967.
It is up +0.00% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$2.09
Open:
$2.18
24h Volume:
40,967
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.91
$2.18
1-Week Range:
$1.91
$2.18
52-Week Range:
$1.91
$2.18
Medicus Pharma Ltd Stock (MDCX) Company Profile
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| MDCX | 2.09 | 0 | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Medicus Pharma unveils ex-GSK and Pfizer senior as chief medical officer - Proactive Investors Australia
Leadership Changes at Medicus Pharma Ltd - TipRanks
Medicus Pharma Strengthens Leadership Team, Advances Skin Cancer Treatment Trial | MDCX Stock News - StockTitan
Medicus Pharma makes debut on Nasdaq raising $4M to advance skin cancer trialICYMI - Proactive Investors Australia
Medicus Pharma Closes $4M IPO, Trades on Nasdaq - TipRanks
MDCXMDCX Latest Stock News & Market Updates - StockTitan
Medicus Pharma completes IPO, becomes second local life sciences company to go public in 2024 - The Business Journals
Medicus Pharma CEO Dr Raza Bokhari on $4M Nasdaq IPO & Phase 2 trial - Proactive Investors USA
Medicus Pharma prices IPO at $4.125 per unit - MSN
Canada Market's biggest losers: Medicus Pharma Ltd. -40.99%, Bragg Gaming Group Inc. -24.43% at midday - Business Upturn
Canada Market's top losers: Pangenomic Health Inc. down 78.67%, Medicus Pharma Ltd down 42.99% - Business Upturn
Medicus Pharma announces pricing of US IPO - Proactive Investors Australia
Medicus Pharma prices IPO at $4.125 per unit (TSXV:MDCX:CA) - Seeking Alpha
Medicus Pharma Announces $4M U.S. IPO Pricing - TipRanks
Exro Technologies Inc (EXRO-T) QuotePress Release - The Globe and Mail
American Express Company (AXP-N) QuotePress Release - The Globe and Mail
Medicus Pharma readies for IPO as it targets $20B industry - The Business Journals
Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail
Medicus Pharma consolidates shares ahead of expected US stock exchange listing - Proactive Investors Australia
Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing - Newsfile
V.MDCX: Medicus Pharma Randomizes First Patient in SKNJCT-003 Phase 2 clinical trial for the treatment of nodular BCC (Basal Cell Carcinoma). - Yahoo Finance
Is Philadelphia a hub for Biotech? 215 Capital is betting on it, says Ajay Raju Biotechnology - The American Bazaar
215 Capital invests $8 million in Medicus Pharma Ltd. - The American Bazaar
Medicus Pharma Ltd. Announces Closing of Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes - Yahoo Finance
FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd. - Yahoo Finance
Medicus Pharma files plan for U.S. IPO - The Business Journals
Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States - Newsfile
Medicus Pharma Opens the Market - Canada NewsWire
Medicus Pharma Ltd. Announces Closing of Business Combination - Newsfile
Medicus Pharma Ltd Stock (MDCX) Financials Data
There is no financial data for Medicus Pharma Ltd (MDCX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.66%
1.11%
Cap:
|
Volume (24h):